Direct visualization of gastrointestinal tract with lanthanide-doped BaYbF5 upconversion nanoprobes.

Biomaterials (2013-07-16)
Zhen Liu, Enguo Ju, Jianhua Liu, Yingda Du, Zhengqiang Li, Qinghai Yuan, Jinsong Ren, Xiaogang Qu
RESUMO

Nanoparticulate contrast agents have attracted a great deal of attention along with the rapid development of modern medicine. Here, a binary contrast agent based on PAA modified BaYbF5:Tm nanoparticles for direct visualization of gastrointestinal (GI) tract has been designed and developed via a one-pot solvothermal route. By taking advantages of excellent colloidal stability, low cytotoxicity, and neglectable hemolysis of these well-designed nanoparticles, their feasibility as a multi-modal contrast agent for GI tract was intensively investigated. Significant enhancement of contrast efficacy relative to clinical barium meal and iodine-based contrast agent was evaluated via X-ray imaging and CT imaging in vivo. By doping Tm(3+) ions into these nanoprobes, in vivo NIR-NIR imaging was then demonstrated. Unlike some invasive imaging modalities, non-invasive imaging strategy including X-ray imaging, CT imaging, and UCL imaging for GI tract could extremely reduce the painlessness to patients, effectively facilitate imaging procedure, as well as rationality economize diagnostic time. Critical to clinical applications, long-term toxicity of our contrast agent was additionally investigated in detail, indicating their overall safety. Based on our results, PAA-BaYbF5:Tm nanoparticles were the excellent multi-modal contrast agent to integrate X-ray imaging, CT imaging, and UCL imaging for direct visualization of GI tract with low systemic toxicity.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Ytterbium, chips, 99.9% trace rare earth metals basis
Sigma-Aldrich
Ytterbium, powder, ≥99.9% trace rare earth metals basis
Sigma-Aldrich
Ytterbium, ingot, 99.9% trace rare earth metals basis
Sigma-Aldrich
Ytterbium, chunks, 99.9% trace metals basis